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Ren-Chao Zhang, Xiao-Wu Xu, Yu-Cheng Zhou, Di Wu, Harsha Ajoodhea, Ke Chen and Yi-Ping Mou*Abstract
Mixed mucinous cystadenoma with serous cystadenoma of the pancreas is rare. There have been only two
previous case reports in the English-language literature. We present a case of a 46-year-old woman who was
diagnosed with mixed mucinous cystadenoma with serous cystadenoma of the pancreas. Computed tomography
and magnetic resonance imaging showed a cystic neoplasm in the dorsal/proximal body of the pancreas with a
clear-margin multilocular cavity and enhanced internal septum. The patient underwent laparoscopic central
pancreatectomy. The diagnosis of mixed mucinous cystadenoma with serous cystadenoma of the pancreas was
confirmed by pathological examination. The patient was followed up for 3 months and there were no signs of
recurrence, or pancreatic exocrine or endocrine insufficiency. To the best of our knowledge, this is the first reported
case treated by laparoscopic central pancreatectomy.
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Pancreatic cystic lesions are being detected with increasing
frequency due to high-resolution imaging. The prevalence
of incidentally detected pancreatic cysts on magnetic res-
onance imaging is 13.5%, and increases with age [1]. Pan-
creatic cystic neoplasms have a wide range of diagnostic
possibilities, including serous cystic neoplasm, mucinous
cystic neoplasm, intraductal papillary mucinous neoplasm
and solid-pseudopapillary neoplasm. A mixed mucinous
cystadenoma (MCA) with serous cystadenoma (SCA) of
the pancreas is rare. There have been only two previous
case reports in the English-language literature [2,3]. We
present here a case of mixed MCA with SCA in the dorsal/
proximal body of the pancreas. The cystic neoplasm was
resected by laparoscopic central pancreatectomy (LCP).Case presentation
A 46-year-old woman was admitted to our department
because of epigastric dull pain for 1 year. She had no* Correspondence: mouyp@srrsh.com
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unless otherwise stated.fever, no nausea or vomiting, no diarrhea or melena, and
no weight loss. Her past medical and surgical history
was unremarkable. The physical examination found no
abnormalities. The laboratory tests, including tumor
markers (carcinoembryonic antigen (CEA), alpha fetopro-
tein, carbohydrate antigen 19–9, carbohydrate antigen 724
and carbohydrate antigen 242) were all within normal
limits. Computed tomography and magnetic resonance
imaging disclosed a 10 × 14-mm cystic neoplasm in the
dorsal/proximal body of the pancreas with a clear-margin
multilocular cavity and enhanced internal septum (Figures 1
and 2). The cystic neoplasm was deep in the pancreatic par-
enchyma (less than 3 mm from the main pancreatic duct).
From the medical history and the imaging findings, the
preoperative diagnosis was a probable cystic neoplasm in
the proximal body of the pancreas. Laparoscopic central
pancreatectomy was performed.
The patient was placed in the supine position with her
head slightly elevated under general anesthesia. The sur-
geon and the second assistant, who held the laparoscope,
stood on the right side of the patient and the first assistant
stood on the left. Carbon dioxide pneumoperitoneum was
established (CO2 at 15 mmHg) using a Veress needle. OneLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography scan showing a 10 × 14-mm
cystic neoplasm (arrow) in the proximal body of the pancreas.
Figure 3 The location of the trocars.
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the umbilicus. A 30° telescope was inserted to examine
the peritoneal cavity to rule out metastasis disease. After
general examination, the other four trocars (one of 12 mm
and three of 5 mm) were inserted into the left upper flank,
left flank, right upper flank and right flank quadrants; the
five trocars were arranged in a V-shape (Figure 3).
The gastrocolonic ligament was divided to give entrance
to the lesser sac with a Harmonic scalpel (Harmonic Ace
scalpel, Ethicon Endo-Surgery, Inc, Cincinnati, OH). The
mobilization of the pancreas began at the superior border
until the common hepatic artery and the proximal splenic
artery were visible (Figure 4A). Then the pancreas was
mobilized at the inferior border to expose the superior
mesenteric vein, the splenomesenteric confluence and the
portal vein (Figure 4B). After creating a tunnel behind theFigure 2 Magnetic resonance imaging. There is a 10 × 14-mm
cystic neoplasm (arrow) in the proximal body of the pancreas with a
clear-margin multilocular cavity and enhanced internal septum.neck of the pancreas, the pancreas was transected 2 cm
proximal to the right side of the tumor with an endo-
scopic linear stapler (Endocutter 60 staple, blue cartridge;
Ethicon Endo-Surgery, Inc, Cincinnati, OH) (Figure 4C).
Because of the extent of the pancreatic disease, the central
part of the pancreas was dissected from the splenic
artery and vein by division of vascular branches with the
Harmonic scalpel and vascular clips. The distal transection
(2 cm distal to the left side of the tumor) of the pancreas
was performed with the Harmonic scalpel (Figure 4D).
The frozen section showed a pancreatic benign cystic neo-
plasm with negative margins.
Next, an end-to-side pancreaticojejunostomy was
performed [4,5]. A row of 3–0 Vicryl suture (coated poly-
glactin 910 suture, Ethicon Products, Johnson & Johnson,
Somerville, NJ) was placed with interrupted stitches be-
tween the jejunal serosa and the posterior side of the pan-
creatic capsule (Figure 4F). The jejunum was opened with
the Harmonic scalpel, suitable for distal pancreatic stump.
The posterior layer was performed with continuous 3–0
Vicryl suture between the pancreas (parenchyma and cap-
sule) and the full thickness of the jejunum (Figure 4G).
The anterior layer was performed in the same way as
the posterior layer. Finally, a side-to-side jejunojeju-
nostomy was performed with an endoscopic linear stapler
(Endocutter 60 staple, white cartridge). Two drainage tubes
were left close to the proximal pancreatic remnant and
pancreaticojejunostomy.
The operative time was 240 min and the blood loss was
50 ml. The postoperative course was uneventful. The
Figure 4 Laparoscopic central pancreatectomy. (A) Mobilizing
the superior border of the pancreas. (B) Mobilizing the inferior
border and back of the pancreas. (C) Transecting with a 60-mm
linear stapler on the right side of the lesion. (D) Transecting the
distal pancreas. (E) View after the central pancreatectomy. (F) Suturing
the jejunal serosa to the posterior capsule of the pancreas. (G) Suturing
the full thickness of the jejunum to the pancreas (parenchyma and
capsule). (H) Final view after reconstruction. CHA, common hepatic
artery; CS, cephalic stump; DP, distal pancreas; GDA, gastroduodenal
artery; J, jejunum; P, pancreas; PJ, pancreaticojejunostomy; PV, portal
vein; SA, splenic artery; SMV, superior mesenteric venous; SV,
splenic vein.
Figure 5 Resected specimen of the mixed mucinous
cystadenoma with serous cystadenoma of the pancreas.
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The patient was discharged on postoperative day 8.
She was followed up 3 months later and there were
no signs of recurrence, or pancreatic exocrine or endo-
crine insufficiency.
The final pathological diagnosis confirmed mixed
MCA with SCA of the pancreas. The gross finding was a
15 mm × 15 mm round cystic mass (Figure 5). Further-
more, the cystic mass was multilocular with a fibrous
capsule. Microscopically, the cystic wall consisted of
fibrous tissues with ovarian-like stroma. The cysts werelined by mucous columnar epithelium or cuboidal epi-
thelium (Figure 6).
Discussion
The concurrent occurrence of SCA and a variety of pri-
mary pancreatic neoplasms, such as pancreatic neuroen-
docrine tumor, ductal adenocarcinoma, neuroendocrine
carcinoma or intraductal papillary mucinous neoplasm,
has been reported [6-9]. MCA has also been reported to
occur synchronously with a variety of primary pancreatic
neoplasms, such as malignant fibrous histiocytoma, ana-
plastic carcinoma, osteoclast-like giant cell tumor, carci-
nosarcoma or sarcomatous stroma [10-14]. We reported
a rare case of mixed MCA with SCA of the pancreas. To
our knowledge, only two cases of mixed SCA with MCA
of the pancreas have been reported in the English-
language literature [2,3]. Abe et al. [2] reported on a
patient who presented with a 6-cm SCA in which the
neoplastic cells were interspersed with the neoplastic
cells of the MCA in the head of the pancreas. Karidis
et al. [3] reported on a patient who presented with
mixed serous–mucinous cystadenoma at the pancre-
atic body coexistent with an adenocarcinoma of the
pancreatic head.
To date, the origin of mixed MCA with SCA of the
pancreas is still unclear. MCA has been thought to arise
from duct cells, whereas SCA has been thought to arise
from centroacinar cells [15]. Abe et al. [2] and Bogomoletz
et al. [15] reported that the duct cells of the smallest
intralobular ducts were adjacent to or imperceptibly
merging into the centroacinar cells. The duct cells, cen-
troacinar cells and acinar epithelial cells of the pancreas
have a common developmental precursor, which diffe-
rentiates into each type of stem cell [16]. Therefore, asso-
ciated oncogenic mutations may occur in the common
Figure 6 Histological features of the mixed mucinous cystadenoma with serous cystadenoma of the pancreas. The arrowhead indicates
the mucous columnar epithelium and the arrow indicates the cuboidal epithelium. (A) H & E stain, ×100. (B) H & E stain, ×400. Scale bars: 100 μm.
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cinar cells, which leads to mixed MCA with SCA of the
pancreas [2].
The American College of Gastroenterology practice
guidelines published in 2007 propose that mucinous
lesions are characterized by a macrocystic lesion con-
taining viscous fluid rich in CEA, whereas serous lesions
have the characteristics of a microcystic morphology
with non-viscous fluid and a low level of CEA [17]. Most
experts recommend that periodical follow-up for SCA
unless the tumor becomes symptomatic and surgical
resection for MCA [18]. However, it is difficult to diagnose
mixed MCA with SCA of the pancreas before an oper-
ation. Including our case, no case has been confirmed
before an operation [2,3]. This interesting phenomenon
adds to the challenges in the clinical decision-making in
the management of small pancreatic cystic neoplasms. In
our case, the patient complained of epigastric dull pain
and she was nervous because of the pancreatic cystic neo-
plasm with an unconfirmed characteristic. After ruling
out other diseases and adequate communication with the
patient, surgical resection of the pancreatic cystic neo-
plasm was performed. Finally, mixed MCA with SCA of
the pancreas was confirmed by pathological examination.
Therefore, evaluation of pancreatic cystic neoplasm should
be on a case-to-case basis [18].
Function-preserving pancreatectomy, especially enucle-
ation and central pancreatectomy, is thought to be an
ideal procedure for benign or low-grade malignant tumors
[19]. Central pancreatectomy is an alternative procedure,
if the tumor is close to the main pancreatic duct. It has
been reported that LCP for benign or low-grade malignant
tumors in the pancreatic neck or proximal body of the
pancreas is feasible and safe [20,21]. However, there are
no reports for LCP for mixed MCA with SCA of the pan-
creas. In our case, the cystic neoplasm of unconfirmed
characteristic was located in the dorsal/proximal body of
the pancreas and deep in the parenchyma (less than 3 mm
from the main pancreatic duct), which contraindicatedenucleation or wedge-shaped resection. LCP was an
optimal choice of treatment for the patient in whom
complicated lymphadenectomy was not necessary. The
intraoperative frozen section supported this surgical pro-
cedure. Because of the difficulty of identifying an undilated
Wirsung duct, an end-to-side pancreaticojejunostomy was
executed for the patient without pancreatic fistula. The
utility of this method for this case is supported by our suc-
cessful intraoperative and postoperative results. Compared
with open surgery, LCP is associated with lower blood loss
and shorter hospital stay, which show its advantages as a
minimally invasive operation [21-23]. However, although
LCP is a promising procedure, it needs to be validated by
more clinical data.
Conclusions
Mixed MCA with SCA of the pancreas is very rare, and
an accurate preoperative diagnosis is difficult. Being aware
of the existence of this disease allows for timely manage-
ment of the pancreatic cystic neoplasm. To the best of our
knowledge, this was the first reported case treated by LCP.
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